• Hims & Hers Health has broadened its telehealth footprint with Hers Hair launching in the UK and the Hers platform entering Australia, while also adding an experienced Chief Accounting Officer to support its expanding operations.
• The business has been preparing for potential regulatory easing on peptide compounding by acquiring a peptide facility and starting ingredient testing, which directly links recent policy headlines to its vertically integrated care model.
• We will examine how Hims & Hers Health’s peptide preparation reshapes its investment narrative as expansion and regulation begin to intersect.

Spot 33 healthcare AI stocks that, like Hims & Hers Health, are leaning into telehealth, personalised treatment plans, and regulatory…